{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:17:36Z","timestamp":1789129056401,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.saa.2021.119682","type":"journal-article","created":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T00:11:31Z","timestamp":1615680691000},"page":"119682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Simultaneous determination of dorzolamide and timolol by first-order derivative UV spectroscopy in simulated biological fluid for in vitro drug release testing"],"prefix":"10.1016","volume":"255","author":[{"given":"Srushti","family":"Tambe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purnima","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.saa.2021.119682_b0005","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"issue":"10108","key":"10.1016\/j.saa.2021.119682_b0010","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","article-title":"Glaucoma","volume":"390","author":"Jonas","year":"2017","journal-title":"The Lancet"},{"issue":"11","key":"10.1016\/j.saa.2021.119682_b0015","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.saa.2021.119682_b0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0970-0218.116348","article-title":"Glaucoma: An emerging peril","volume":"38","author":"Saxena","year":"2013","journal-title":"Indian J. Community Med."},{"issue":"12","key":"10.1016\/j.saa.2021.119682_b0025","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1517\/14656566.2014.936850","article-title":"Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice","volume":"15","author":"Holl\u00f3","year":"2014","journal-title":"Expert Opin. Pharmacother."},{"issue":"12","key":"10.1016\/j.saa.2021.119682_b0030","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2165\/00002512-200724120-00004","article-title":"Use of fixed-dose combination drugs for the treatment of glaucoma","volume":"24","author":"Khouri","year":"2007","journal-title":"Drugs Aging"},{"key":"10.1016\/j.saa.2021.119682_b0035","first-page":"1","article-title":"Considerations in glaucoma therapy: fixed combinations versus their component medications","volume":"4","author":"Higginbotham","year":"2010","journal-title":"Clin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.saa.2021.119682_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002512-200522010-00001","article-title":"Management of glaucoma: focus on pharmacological therapy","volume":"22","author":"Marquis","year":"2005","journal-title":"Drugs Aging"},{"issue":"2","key":"10.1016\/j.saa.2021.119682_b0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11095-018-2557-4","article-title":"Glaucoma-next generation therapeutics: impossible to possible","volume":"36","author":"Adams","year":"2019","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.saa.2021.119682_b0050","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/00003495-200059030-00003","article-title":"Pharmacological therapy for glaucoma","volume":"59","author":"Hoyng","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.saa.2021.119682_b0055","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0099-5428(08)60566-3","volume":"Vol. 16","author":"Mazzo","year":"1987","journal-title":"Timolol maleate, Analytical profiles of drug substances"},{"key":"10.1016\/j.saa.2021.119682_b0060","series-title":"Becker-Shaffer's Diagnosis and Therapy of the Glaucomas (Eighth Edition)","first-page":"392","article-title":"CHAPTER 25 - Adrenergic antagonists","author":"Stamper","year":"2009"},{"issue":"5","key":"10.1016\/j.saa.2021.119682_b0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1358\/dot.1997.33.5.430476","article-title":"Dorzolamide hydrochloride: a topically active, carbonic anhydrase inhibitor for the treatment of glaucoma","volume":"33","author":"Sugrue","year":"1997","journal-title":"Drugs of today"},{"key":"10.1016\/j.saa.2021.119682_b0070","doi-asserted-by":"crossref","unstructured":"M.-P. Quint, J. Grove, S. M. Thomas, Dorsolamide Hydrochloride. Analytical profiles of drug substances and excipients, Vol. 26, Elsevier, Academic Press, pp. 1999 283-317.","DOI":"10.1016\/S0099-5428(08)60625-5"},{"issue":"2","key":"10.1016\/j.saa.2021.119682_b0075","first-page":"389","article-title":"Rational use of the fixed combination of dorzolamide\u2013timolol in the management of raised intraocular pressure and glaucoma","volume":"2","author":"Yeh","year":"2008","journal-title":"Clin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.saa.2021.119682_b0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1752-153X-6-105","article-title":"Simultaneous determination of moxifloxacin and cefixime by first and ratio first derivative ultraviolet spectrophotometry","volume":"6","author":"Attimarad","year":"2012","journal-title":"Chem. Cent. J."},{"issue":"3","key":"10.1016\/j.saa.2021.119682_b0085","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jpba.2006.01.007","article-title":"Simultaneous determination of lamivudine and stavudine in antiretroviral fixed dose combinations by first derivative spectrophotometry and high performance liquid chromatography","volume":"41","author":"Kapoor","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.saa.2021.119682_b0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.14227\/DT240317P38","article-title":"Physicochemical properties of buffers used in simulated biological fluids with potential application for in vitro dissolution testing: a mini-review","volume":"24","author":"Mauger","year":"2017","journal-title":"Dissolution Technol."},{"key":"10.1016\/j.saa.2021.119682_b0095","first-page":"15","article-title":"C; Loebenberg, R, Almukainzi, M","volume":"18","author":"Marques","year":"2011","journal-title":"Simulated biological fluids with possible application in dissolution testing, Dissolution Technol."},{"issue":"4","key":"10.1016\/j.saa.2021.119682_b0100","first-page":"281","article-title":"Formulation and In Vitro-In Vivo Correlation of Timolol Maleate Ocular Insert","volume":"4","author":"Thakral","year":"2015","journal-title":"Indonesian J. Pharm."},{"issue":"2","key":"10.1016\/j.saa.2021.119682_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191415","article-title":"Enhancement of pharmacokinetic and pharmacological behavior of ocular dorzolamide after factorial optimization of self-assembled nanostructures","volume":"13","author":"Afify","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.saa.2021.119682_b0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.saa.2014.02.005","article-title":"Novel spectrophotometric methods for simultaneous determination of timolol and dorzolamide in their binary mixture","volume":"126","author":"Lotfy","year":"2014","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"2","key":"10.1016\/j.saa.2021.119682_b0115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0731-7085(01)00627-6","article-title":"Simultaneous determination of dorzolamide HCL and timolol maleate in eye drops by two different spectroscopic methods","volume":"28","author":"Erk","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"5","key":"10.1016\/j.saa.2021.119682_b0120","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0731-7085(01)00529-5","article-title":"Application of TLC-densitometry, first-derivative UV-spectrophotometry and ratio derivative spectrophotometry for the determination of dorzolamide hydrochloride and timolol maleate","volume":"27","author":"Bebawy","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"9","key":"10.1016\/j.saa.2021.119682_b0125","first-page":"745","article-title":"A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form","volume":"50","author":"Sharma","year":"2012","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.saa.2021.119682_b0130","unstructured":"R. Kanchan, M. Shikha, N. Roy, R. Rane, Simultaneous RP-HPLC determination of dorzolamide hydrochloride and timolol maleate in pharmaceutical preparations, Trade Science Inc 7 (8) (2008)."},{"key":"10.1016\/j.saa.2021.119682_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19440049.2020.1769199","article-title":"Dispersive liquid\u2013liquid microextraction based on the solidification of floating organic droplets for HPLC determination of three strobilurin fungicides in cereals","author":"Huang","year":"2020","journal-title":"Food Addit. Contam. Part A"},{"key":"10.1016\/j.saa.2021.119682_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijleo.2019.164010","article-title":"The application of artificial intelligence system and regression methods based on the spectrophotometric method for fast simultaneous determination of naphazoline and antazoline in ophthalmic formulation","volume":"203","author":"Shahrokhi","year":"2020","journal-title":"Optik"},{"issue":"3","key":"10.1016\/j.saa.2021.119682_b0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14227\/DT180311P15","article-title":"Simulated biological fluids with possible application in dissolution testing","volume":"18","author":"Marques","year":"2011","journal-title":"Dissolution Technol."},{"key":"10.1016\/j.saa.2021.119682_b0150","series-title":"Introduction to pharmaceutical chemical analysis","author":"Hansen","year":"2011"},{"key":"10.1016\/j.saa.2021.119682_b0155","series-title":"Preparation of calibration curves: a guide to best practice","author":"Barwick","year":"2003"},{"issue":"1","key":"10.1016\/j.saa.2021.119682_b0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/2229-5186.79345","article-title":"Methods for the determination of limit of detection and limit of quantitation of the analytical methods","volume":"2","author":"Shrivastava","year":"2011","journal-title":"Chron. Young Sci."},{"key":"10.1016\/j.saa.2021.119682_b0165","unstructured":"I. Ich, editor Q2 (R1): Validation of analytical procedures: text and methodology, 2005."},{"issue":"7","key":"10.1016\/j.saa.2021.119682_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-020-01791-0","article-title":"Design, Characterization, and Application of a pH-Triggered In Situ Gel for Ocular Delivery of Vinpocetine","volume":"21","author":"Ma","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.saa.2021.119682_b0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejpb.2017.01.008","article-title":"Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies","volume":"114","author":"Fathalla","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.saa.2021.119682_b0180","series-title":"In Vitro Drug Release Testing of Special Dosage Forms","author":"Fotaki","year":"2019"}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142521002584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142521002584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T01:43:39Z","timestamp":1761356619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142521002584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":36,"alternative-id":["S1386142521002584"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2021.119682","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous determination of dorzolamide and timolol by first-order derivative UV spectroscopy in simulated biological fluid for in vitro drug release testing","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2021.119682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119682"}}